The Intrinsically Disordered W Protein Is Multifunctional during Henipavirus Infection, Disrupting Host Signalling Pathways and Nuclear Import.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
18 08 2020
Historique:
received: 13 06 2020
revised: 10 08 2020
accepted: 13 08 2020
entrez: 23 8 2020
pubmed: 23 8 2020
medline: 20 3 2021
Statut: epublish

Résumé

Nipah and Hendra viruses are highly pathogenic, zoonotic henipaviruses that encode proteins that inhibit the host's innate immune response. The W protein is one of four products encoded from the P gene and binds a number of host proteins to regulate signalling pathways. The W protein is intrinsically disordered, a structural attribute that contributes to its diverse host protein interactions. Here, we review the role of W in innate immune suppression through inhibition of both pattern recognition receptor (PRR) pathways and interferon (IFN)-responsive signalling. PRR stimulation leading to activation of IRF-3 and IFN release is blocked by henipavirus W, and unphosphorylated STAT proteins are sequestered within the nucleus of host cells by W, thereby inhibiting the induction of IFN stimulated genes. We examine the critical role of nuclear transport in multiple functions of W and how specific binding of importin-alpha (Impα) isoforms, and the 14-3-3 group of regulatory proteins suggests further modulation of these processes. Overall, the disordered nature and multiple functions of W warrant further investigation to understand henipavirus pathogenesis and may reveal insights aiding the development of novel therapeutics.

Identifiants

pubmed: 32824665
pii: cells9081913
doi: 10.3390/cells9081913
pmc: PMC7465373
pii:
doi:

Substances chimiques

Intrinsically Disordered Proteins 0
Receptors, Pattern Recognition 0
Viral Proteins 0
Interferons 9008-11-1

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ErratumIn

Références

J Gen Virol. 2006 Dec;87(Pt 12):3649-3653
pubmed: 17098981
J Virol. 2002 Sep;76(18):9284-97
pubmed: 12186912
PLoS Pathog. 2015 Mar 17;11(3):e1004739
pubmed: 25782006
Nat Commun. 2018 Sep 12;9(1):3703
pubmed: 30209309
J Virol. 2016 Jun 24;90(14):6326-6343
pubmed: 27147733
PLoS Pathog. 2010 Nov 11;6(11):e1001186
pubmed: 21085610
J Clin Microbiol. 2018 May 25;56(6):
pubmed: 29643201
J Virol. 2000 Sep;74(17):7989-96
pubmed: 10933707
J Gen Virol. 2002 Apr;83(Pt 4):753-757
pubmed: 11907323
Int J Biochem Cell Biol. 2010 Sep;42(9):1416-29
pubmed: 20398786
EMBO J. 1998 Feb 16;17(4):1087-95
pubmed: 9463386
Biochemistry. 1999 Sep 21;38(38):12499-504
pubmed: 10493820
Proc Natl Acad Sci U S A. 2012 Aug 28;109(35):13996-4000
pubmed: 22891297
Drug Discov Today. 2016 Feb;21(2):278-87
pubmed: 26456530
Genes Dev. 1998 Jul 1;12(13):2061-72
pubmed: 9649509
J Virol. 2006 Nov;80(22):11062-73
pubmed: 16971425
Immunol Rev. 2013 Sep;255(1):5-12
pubmed: 23947343
Curr Protoc Bioinformatics. 2020 Jun;70(1):e99
pubmed: 32237272
Int Rev Immunol. 2002 Jul-Oct;21(4-5):305-37
pubmed: 12486817
Virology. 1995 Dec 1;214(1):139-49
pubmed: 8525609
Front Microbiol. 2019 May 16;10:1097
pubmed: 31156602
J Biol Chem. 2007 Feb 23;282(8):5101-5
pubmed: 17170104
Annu Rev Pharmacol Toxicol. 2000;40:617-47
pubmed: 10836149
J Virol. 1999 Dec;73(12):9928-33
pubmed: 10559305
Curr Opin Virol. 2016 Feb;16:120-125
pubmed: 26978066
Enzyme. 1990;44(1-4):244-9
pubmed: 1966841
J Gen Virol. 2005 Jul;86(Pt 7):1869-1877
pubmed: 15958664
Virology. 1996 May 15;219(2):339-49
pubmed: 8638399
J Virol. 2000 Nov;74(21):9972-9
pubmed: 11024125
Microbes Infect. 2002 May;4(6):647-55
pubmed: 12048034
J Virol. 2012 Aug;86(16):8581-91
pubmed: 22674974
Nature. 2005 Jul 21;436(7049):401-5
pubmed: 16007075
Nat Rev Immunol. 2014 Aug;14(8):546-58
pubmed: 25060580
J Virol. 2009 Aug;83(16):7828-41
pubmed: 19515782
J Gen Virol. 2019 Dec;100(12):1593-1594
pubmed: 31609197
Oncogene. 2001 Oct 1;20(44):6331-8
pubmed: 11607836
Virology. 2010 Aug 15;404(1):78-88
pubmed: 20552729
Oncogene. 2001 Feb 15;20(7):800-11
pubmed: 11314014
J Virol. 2002 May;76(10):5251-9
pubmed: 11967338
J Virol. 2017 Nov 14;91(23):
pubmed: 28904190
Trends Cell Biol. 2004 Sep;14(9):505-14
pubmed: 15350979
Biochem Biophys Res Commun. 2001 Apr 27;283(1):255-9
pubmed: 11322797
J Gen Virol. 2009 Feb;90(Pt 2):398-404
pubmed: 19141449
Nature. 2001 Oct 18;413(6857):732-8
pubmed: 11607032
J Virol. 2003 Jul;77(14):7945-56
pubmed: 12829834
Am J Pathol. 2002 Dec;161(6):2153-67
pubmed: 12466131
Virology. 2004 Jul 20;325(1):137-48
pubmed: 15231393
Nat Commun. 2015 Jun 24;6:7483
pubmed: 26105519
J Virol. 2020 Jul 1;94(14):
pubmed: 32321809
J Immunol. 2015 Jul 1;195(1):289-97
pubmed: 25994966
Cell Host Microbe. 2019 Oct 9;26(4):493-503.e6
pubmed: 31600501
Cancer Cell. 2018 Mar 12;33(3):495-511.e12
pubmed: 29502954
Cell Host Microbe. 2012 May 17;11(5):528-37
pubmed: 22607805
J Virol. 2002 Jun;76(11):5532-9
pubmed: 11991981
Virology. 2002 May 10;296(2):251-62
pubmed: 12069524
J Virol. 2004 Jun;78(11):5633-41
pubmed: 15140960
Sci Rep. 2019 Nov 13;9(1):16710
pubmed: 31723221
J Virol. 2004 May;78(10):5358-67
pubmed: 15113915
Front Immunol. 2019 Jan 08;9:3086
pubmed: 30671058
Immunity. 2000 Oct;13(4):539-48
pubmed: 11070172
J Mol Biol. 1999 Jul 30;290(5):1031-41
pubmed: 10438601
Science. 2003 May 16;300(5622):1148-51
pubmed: 12702806
Virology. 2002 Nov 10;303(1):15-32
pubmed: 12482655
J Virol. 2005 May;79(10):6078-88
pubmed: 15857993
J Virol. 1999 Jul;73(7):5568-76
pubmed: 10364305
J Virol. 2002 Nov;76(22):11476-83
pubmed: 12388709
Virus Res. 2003 Mar;92(1):89-98
pubmed: 12606080
J Infect Dis. 2020 May 11;221(Suppl 4):S401-S406
pubmed: 31853535
Virol J. 2007 Jan 04;4:1
pubmed: 17204159
Nat Rev Immunol. 2014 Jan;14(1):36-49
pubmed: 24362405
Nat Rev Immunol. 2004 Jul;4(7):499-511
pubmed: 15229469
Int Rev Immunol. 2017 Mar 4;36(2):108-121
pubmed: 28060559
J Virol. 2003 Jan;77(2):1501-11
pubmed: 12502864
J Virol. 2014 Jan;88(1):41-53
pubmed: 24131713
J Cell Sci. 2004 Apr 15;117(Pt 10):1875-84
pubmed: 15090593
Nat Struct Biol. 2000 Nov;7(11):1068-74
pubmed: 11062565
J Virol. 2002 May;76(9):4190-8
pubmed: 11932384
PLoS One. 2012;7(3):e31719
pubmed: 22403617
Virology. 2002 Nov 10;303(1):33-46
pubmed: 12482656
Nature. 2012 Jul 26;487(7408):486-90
pubmed: 22810585
N Engl J Med. 2000 Apr 27;342(17):1229-35
pubmed: 10781618
Nature. 2003 Nov 6;426(6962):33-8
pubmed: 14603309
Biophys J. 2020 May 19;118(10):2470-2488
pubmed: 32348724
PLoS Pathog. 2019 Feb 11;15(2):e1007582
pubmed: 30742689
Emerg Infect Dis. 2009 Aug;15(8):1229-35
pubmed: 19751584
Curr Top Microbiol Immunol. 2012;359:79-94
pubmed: 22427111
Mol Cell Biol. 1998 May;18(5):2986-96
pubmed: 9566918
Science. 1995 Apr 7;268(5207):94-7
pubmed: 7701348
Nat Rev Mol Cell Biol. 2007 Mar;8(3):195-208
pubmed: 17287812
Cell Res. 2006 Feb;16(2):141-7
pubmed: 16474426
Virology. 2001 May 10;283(2):230-9
pubmed: 11336548
Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6322-7
pubmed: 11972054
Mol Cell Biol. 2000 Jun;20(11):4159-68
pubmed: 10805757
PLoS Pathog. 2010 Jan 15;6(1):e1000721
pubmed: 20084112
J Virol. 1997 Aug;71(8):6155-67
pubmed: 9223510
Annu Rev Immunol. 2014;32:513-45
pubmed: 24555472
Curr Top Microbiol Immunol. 2012;359:59-78
pubmed: 22695915
Nat Immunol. 2003 May;4(5):491-6
pubmed: 12692549

Auteurs

Sofiya Tsimbalyuk (S)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia.

Emily M Cross (EM)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia.

Mikayla Hoad (M)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia.

Camilla M Donnelly (CM)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia.

Justin A Roby (JA)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia.

Jade K Forwood (JK)

School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW 2678, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH